会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHOD OF PREPARATION OF A SOLUBLE FORMULATION OF WATER-INSOLUBLE PENTACYCLIC AND TETRACYCLIC TERPENOIDS, A SOLUBLE FORMULATION OF A PENTACYCLIC OR TETRACYCLIC TERPENOID AND A PHARMACEUTICAL COMPOSITION CONTAINING THIS SOLUBLE FORMULATION
    • 制备水不溶性的五邻和四环萜烯的可溶配方,戊二酸或四环萜烯的可溶配方和含该可溶配方的药物组合物的制备方法
    • WO2008037226A3
    • 2008-07-31
    • PCT/CZ2007000088
    • 2007-09-25
    • UNIVERZITA KARLOVA V PRAZE PRIUNIVERZITA PALACKEHO V OLOMOUCI Q A A SSAREK JANHAJDUCH MARIANSVOBODA MICHALNOVAKOVA KATERINASPACILOVA PAVLAKUBELKA TOMASBIEDERMANN DAVID
    • SAREK JANHAJDUCH MARIANSVOBODA MICHALNOVAKOVA KATERINASPACILOVA PAVLAKUBELKA TOMASBIEDERMANN DAVID
    • A61K31/56C07J63/00C07J71/00
    • C07J71/0047A61K31/56A61K47/6951B82Y5/00C07J63/008
    • The invention relates to a method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, wherein the water-insoluble terpenoid having a free carboxylic, hydroxy or amino functional group is derivatized on this functional group with a substituent selected from the group comprising substituents of general formula Xa bound to the hydroxy group of the terpenoid, wherein Xa is -OC-R-COOH, substituents of general formula Xa bound to the amino group of the terpenoid, wherein Xa is -OC-R-COOH, quarternary ammonium substituents of general formula Xb bound to the carboxy group of the terpenoid, wherein Xb is -(CH2)nN+R3Y-, quarternary ammonium substituents of general formula Xc bound to the carboxy group of the terpenoid, wherein Xc je -(CH2)nR+Y-, substituents of general formula Xd bound to the carboxy group of the terpenoid, wherein Xd represents -R-COOH, glycosylic substituents Xe bound by alpha or beta glycosidic bond to the hydroxy group or to the carboxy group of the terpenoid, wherein Xe is selected from the group comprising glucosyl, galactosyl, arabinosyl, rhamnosyl, lactosyl, cellobiosyl, maltosyl and the 2-deoxyanalogues thereof, and subsequently, the prepared derivative is dissolved in the solution containing water, a cyclodextrin and optionally pharmaceutically acceptable auxiliary substances, forming an inclusion derivative with the cyclodextrin. Object of the invention is further a soluble formulation of a pentacyclic or tetracyclic triterpenoid, containing an inclusion complex of the derivatized pentacyclic or tetracyclic terpenoid with a cyclodextrin, and optionally water and pharmaceutically acceptable auxiliary substances and further a pharmaceutical composition containing the soluble formulation.
    • 本发明涉及制备水不溶性五环和四环萜类的可溶性制剂的方法,其中具有游离羧酸,羟基或氨基官能团的水不溶性萜类在该官能团上被选自以下的取代基衍生化 包含与萜类化合物的羟基结合的通式Xa的取代基,其中Xa是-OC-R-COOH,通式Xa的取代基与萜类化合物的氨基结合,其中Xa是-OC-R-COOH,四元 其中Xb是 - (CH2)nN + R3Y-的通式Xb的铵取代基与通式Xc的季铵取代基结合到萜类化合物的羧基上,其中Xc - (CH2) nR + Y-,通式Xd的取代基与萜类化合物的羧基结合,其中Xd表示-R-COOH,糖基取代基Xe通过α或β糖苷键与羟基或β 其中Xe选自葡糖基,半乳糖基,阿拉伯糖基,鼠李糖基,乳糖基,纤维二糖基,麦芽糖基及其2-脱氧类似物,然后将制备的衍生物溶于含有水,环糊精 和任选的药学上可接受的辅助物质,与环糊精形成包合物衍生物。 本发明的目的还在于含有衍生的五环或四环萜类化合物与环糊精的包合配合物,以及任选的水和药学上可接受的辅助物质的五环或四环三萜类化合物的可溶性制剂以及含有该可溶性制剂的药物组合物。